SEC Filings
| Filing date | Description | Form | Filing Group | Issuer | View |
|---|---|---|---|---|---|
| View HTML EX-101.SCH - XBRL TAXONOMY EXTENSION SCHEMA | Quarterly report which provides a continuing view of a company's financial position |
10-Q |
Quarterly Filings
|
Eidos Therapeutics, Inc. | |
| View HTML | Filing by person(s) reporting owned shares of common stock in a public company >5% |
SC 13D |
Other
|
Eidos Therapeutics, Inc. | |
| View HTML | Statement of changes in beneficial ownership of securities |
4 |
3,4,5
|
Eidos Therapeutics, Inc. | |
| View HTML | Filing of certain prospectuses and communications in connection with business combination transactions |
425 |
Other
|
Eidos Therapeutics, Inc. | |
| View HTML | Filing of certain prospectuses and communications in connection with business combination transactions |
425 |
Other
|
Eidos Therapeutics, Inc. | |
| View HTML EX-101.SCH - XBRL TAXONOMY EXTENSION SCHEMA | Report of unscheduled material events or corporate event |
8-K |
Current Reports
|
Eidos Therapeutics, Inc. | |
| View HTML | An amendment to a SC 13D filing |
SC 13D/A |
Other
|
Eidos Therapeutics, Inc. | |
| View HTML | Filing of certain prospectuses and communications in connection with business combination transactions |
425 |
Other
|
Eidos Therapeutics, Inc. | |
| View HTML EX-101.SCH - XBRL TAXONOMY EXTENSION SCHEMA | Report of unscheduled material events or corporate event |
8-K |
Current Reports
|
Eidos Therapeutics, Inc. | |
| View HTML | Filing of certain prospectuses and communications in connection with business combination transactions |
425 |
Other
|
Eidos Therapeutics, Inc. |
Displaying 41 - 50 of 238 results
Data provided by Kaleidoscope.